Asahi Kasei Pharma Corporation is a pharmaceutical company ranked in the top 20 in the Japanese pharmaceutical market.
They will be held an open call for research for drug discovery on below areas.
Since they accelerate their open innovation project in 2018, they expect more opportunity from the EU.
The areas: Neurodegenerative Disease, Autoimmune Disease, Emergency, Bone/cartilage, Muscle disease.
Submitting proposals period: 14:00 on January 7 to 17:00 on February 9, 2021 (JST)*
*Please mind submissions on out of period will be invalid.
Amount of grant:
Up to US$100,000/project/year for “Research collaboration”
Up to US$20,000/project/year for “Research funding”
If applicants have any questions in advance, contact firstname.lastname@example.org